| Not Yet Recruiting | First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Healthy Subjects (HS), SLE (Systemic Lupus) | Phase 1 | 2026-04-01 |
| Not Yet Recruiting | First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Healthy Subjects, Hyperlipidemia, Hypertriglyceridemia | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Can Small Cell Lung Cancer | Phase 2 | 2025-08-01 |
| Not Yet Recruiting | A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Cur NPC, HNSCC, Recurrence | Phase 2 / Phase 3 | 2025-01-01 |
| Recruiting | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-12-31 |
| Recruiting | To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer Stomach Neoplasms, Solid Tumor | Phase 2 / Phase 3 | 2024-08-15 |
| Recruiting | A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors MTD | Phase 1 / Phase 2 | 2024-03-09 |
| Recruiting | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 / Phase 2 | 2024-03-01 |
| Not Yet Recruiting | A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Can Bladder Cancer | Phase 1 / Phase 2 | 2024-02-15 |
| Recruiting | A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 / Phase 2 | 2023-07-03 |
| Unknown | To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Metastatic Colorectal Cancer HER2 Gene Mutation | Phase 2 / Phase 3 | 2023-05-12 |
| Unknown | IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant T HER2 Gene Mutation | Phase 1 / Phase 2 | 2023-04-25 |
| Unknown | A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors. Advanced Malignant Solid Tumor | Phase 1 / Phase 2 | 2022-06-24 |
| Unknown | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 / Phase 2 | 2022-06-22 |
| Unknown | Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 / Phase 2 | 2021-08-31 |
| Unknown | Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2021-07-06 |